The following table provides an overview of the latest patents of Serenity Pharmaceuticals Llc that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2381923Jun 7, 2023Safe Desmopressin Administration1
EP3278809Nov 20, 2019Safe Desmopressin Administration1
EP2442821Jun 14, 2017Safe Desmopressin Administration1